Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease

NCT02559713 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Colitis, Ulcerative
Crohn's Disease

Interventions

DRUG: Vedolizumab

Sponsor

Takeda